Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Glivec Monotherapy vs Glivec + Interferon in Newly Diagnosed CML
NCT00390897Phase 4Completed
- Sponsor
- Fundación PETHEMA
- Start
- Jul 2003
- Primary completion
- Oct 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of imatinib in chronic myeloid leukemia (CML), sponsored by Fundación PETHEMA. Started Jul 2003; status: completed.
02
Drugs
03
Conditions
chronic myeloid leukemia (CML)
Beyond the preview
Go deeper on NCT00390897.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00390897.